HIV Malignancy Specimens for Research at No Charge
From Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 NCI encourages applications for pragmatic clinical trials to generate evidence that directly informs decision-making among patients, providers, …
From RFA-CA-24-005 This Notice of Funding Opportunity (NOFO) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects …
Through this Notice of Special Interest (NOSI), NOT-CA-23-070 the National Cancer Institute (NCI) is a continuation of NOT-CA-20-022, “High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers, which expired …
The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications to expand the research scope and leverage the …
Two new research opportunities from NIH/NCI! The purpose of these Notice of Funding Opportunity (NOFO) is to solicit developmental/exploratory research to better understand the mechanisms of persistent oral human papillomavirus …
Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI’s Center for Global Health is now offering full-time, one-year …
This initiative will support intervention research that addresses structural racism and discrimination (SRD) in order to improve minority health or reduce health disparities. Earliest submission date: February 24, 2023 Letter …
Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI’s Center for Global Health is now offering full-time, one-year …
Through this Funding Opportunity Announcement (FOA) RFA-CA-22-051, the National Cancer Institute (NCI) solicits applications from institutions/organizations to participate as Clinical Sites for the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network. …
With the support of the Equity Council, NCI launched EIAP in late 2021 to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. The cancer research enterprise …
